Stéphane Huguet
A French and Canadian citizen, trained as an emergency care physician and later graduated with the MBA from
INSEAD, France. He held several managerial positions in the pharmaceutical industry, first with
Novartis in Switzerland and in the USA, where he was responsible for the bone metabolism Business Unit and then with
Fournier Pharma as Director of Global Marketing and CEO of the Canadian subsidiary. In the late nineties, S. Huguet was recruited as President of Phoenix international, the largest bio analytical and phase I/II CRO in the world, which was listed on the NYSE. After the take over of Phoenix by
MDS pharma services, S Huguet came back to France as CEO of
Mutabilis, a biotechnology company, based out of
Necker hospital in Paris. In his career aside from demonstrating general management abilities, Dr Huguet was responsible for submitting three registration files which were approved by the regulatory authorities, one with the
FDA, one with the HPB and one with the CPMP commission. Most recently he raised 8 millions euros from venture capital to finance
Mutabilis drug discovery programs. Currently Dr Huguet, who serves on the board of several companies, is the founder and CEO of smaXY (satellite management assistant XY) a start up developing tools to improve the productivity of the pharmaceutical field forces.
Service offer
Corporate overview
